Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Finance 150x110Second Quarter 2017 Financial Results

Genmab published its Second Quarter 2017 financial results and held an investor conference call on August 9.  Click here to view the results, here to listen to the archived webcast, here to download the the call as a podcast and here to download the slide presentation. 


Upcoming Events

A list of investor conferences at which Genmab will present, as well as financial report dates and other events, can be found on the Events & Presentations page of this website.  

Download Library

Access Genmab's financial reports, webcasts, presentations and more from the Download Library